Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-09-24 Purchase | 2021-09-28 5:48 pm | LEAP THERAPEUTICS Inc | LPTX | BeiGene Ltd. 10% Owner | 2,543,800 | $2.85 | $7,249,830 | 7,348,437 (Direct) | View |
2021-09-14 Sale | 2021-09-16 6:06 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 347,803 | $28.82 | $10,022,365 | 47,814,827 (Indirect Direct) | View |
2021-08-31 Sale | 2021-09-02 8:40 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 204,358 | $24.09 | $4,922,921 | 47,814,827 (Indirect Direct) | View |
2021-08-04 Sale | 2021-08-05 9:03 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 83,200 | $25.97 | $2,160,781 | 47,814,827 (Indirect Direct) | View |
2021-08-03 Sale | 2021-08-05 9:01 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 41,400 | $25.17 | $1,041,881 | 47,814,827 (Indirect Direct) | View |
2021-07-22 Sale | 2021-07-22 6:23 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 57,900 | $23.71 | $1,373,070 | 47,814,827 (Indirect Direct) | View |
2021-07-20 Sale | 2021-07-22 6:21 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 39,600 | $24.6 | $974,108 | 47,814,827 (Indirect Direct) | View |
2021-07-07 Sale | 2021-07-08 7:11 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 51,300 | $24.24 | $1,243,717 | 47,814,827 (Indirect Direct) | View |
2021-07-06 Sale | 2021-07-08 7:09 pm | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 85,000 | $25.29 | $2,149,295 | 47,815,127 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-05-17 Exercise | 2022-05-19 4:39 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R & D | 999,999 | $3.49 | 1,466,686 (Direct) | View |
2022-05-17 Exercise | 2022-05-19 4:39 pm | N/A 2026-07-13 | BeiGene Ltd. | BGNE | Wang Lai Global Head of R & D | 1,233,947 | $0 | 1,466,686 (Direct) | View |
2022-05-17 Exercise | 2022-05-19 4:39 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R & D | 233,948 | $2.29 | 1,466,686 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 5:12 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Julia Aijun CFO | 61,750 | $0 | 143,299 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 5:10 pm | N/A 2032-02-27 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 22,581 | $0 | 22,581 (Direct) | View |
2022-02-28 Option Award | 2022-03-02 5:07 pm | N/A 2032-02-27 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 22,581 | $0 | 22,581 (Direct) | View |
2021-12-15 Option Award | 2021-12-17 5:05 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R & D | 0 | $30.13 | 174,551 (Indirect) | View |
2021-12-15 Gift | 2021-12-17 5:05 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Lai Global Head of R & D | 116,376 | $0 | 174,551 (Direct) | View |
2021-12-15 Option Award | 2021-12-17 5:03 pm | N/A N/A | BeiGene Ltd. | BGNE | Wu Xiaobin COO | 0 | $30.13 | 968,261 (Indirect) | View |
2021-12-14 Exercise | 2021-12-16 5:50 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 1,500 | $119.96 | 371,331 (Direct) | View |
2021-12-14 Exercise | 2021-12-16 5:50 pm | N/A 2029-06-04 | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 19,500 | $0 | 371,331 (Direct) | View |
2021-11-30 Option Award | 2021-12-02 6:21 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 15,869 | $0 | 0 (Direct) | View |
2021-11-17 Exercise | 2021-11-19 6:18 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 1,500 | $119.96 | 376,011 (Direct) | View |
2021-11-17 Exercise | 2021-11-19 6:18 pm | N/A 2029-06-04 | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 19,500 | $0 | 376,011 (Direct) | View |
2021-10-19 Exercise | 2021-10-21 5:37 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 1,500 | $119.96 | 395,511 (Direct) | View |
2021-10-19 Exercise | 2021-10-21 5:37 pm | N/A 2029-06-04 | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 19,500 | $0 | 395,511 (Direct) | View |
2021-09-20 Exercise | 2021-09-22 6:15 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 6,000 | $119.96 | 415,011 (Direct) | View |
2021-09-20 Exercise | 2021-09-22 6:15 pm | N/A 2029-06-04 | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 78,000 | $0 | 415,011 (Direct) | View |
2021-08-31 Option Award | 2021-09-02 8:39 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 15,374 | $0 | 0 (Direct) | View |
2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 6,914 | $160.4 | 974,206 (Direct) | View |
2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 8,831 | $119.96 | 974,206 (Direct) | View |
2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 5,255 | $174.43 | 974,206 (Direct) | View |
2021-07-15 Exercise | 2021-07-19 4:43 pm | N/A 2028-06-25 | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 273,000 | $0 | 974,206 (Direct) | View |
2021-06-30 Ownership | 2021-07-01 4:55 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Julia Aijun CFO | 0 | $0 | 366,483 (Direct) | View |
2021-06-28 Exercise | 2021-06-30 4:49 pm | N/A N/A | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 1,500 | $29.49 | 506,236 (Direct) | View |
2021-06-28 Exercise | 2021-06-30 4:49 pm | N/A 2026-09-02 | BeiGene Ltd. | BGNE | Huang Jane CMO Hematology | 19,500 | $0 | 506,236 (Direct) | View |
2021-06-16 Option Award | 2021-06-24 12:26 pm | N/A 2031-06-15 | BeiGene Ltd. | BGNE | Yi Qingqing Director | 25,298 | $0 | 25,298 (Direct) | View |
2021-06-16 Option Award | 2021-06-21 4:57 pm | N/A 2031-06-15 | BeiGene Ltd. | BGNE | OYLER JOHN CEO | 1,053,156 | $0 | 55,658,639 (Direct) | View |
2021-06-16 Option Award | 2021-06-21 4:50 pm | N/A 2031-06-15 | BeiGene Ltd. | BGNE | Wang Xiaodong Chairman | 280,839 | $0 | 11,699,072 (Direct) | View |